Healthcare -
Biotechnology - NASDAQ - US
$ 2.237
1.68 %
$ 59.3 M
Market Cap
-2.09
P/E
GANX - CAPITAL EXPENDITURES
Capital Expenditures GANX - Gain Therapeutics, Inc.
-15.4 K
LAST VALUE
59.62%
2 YEAR CAGR
-13.97%
5 YEAR CAGR
0.00%
10 YEAR CAGR